13 hasil
FIELD OF THE INVENTION
The present invention discloses a novel method to isolate a natural flavonoid; inoscavin A indicated in formula 1, from mushroom F. fastuosus, having promising antiprolifertive activity on rhabdomyosarcoma and thereby communicates its application to use it as a medicinal
FIELD OF THE INVENTION
The invention relates to an ethyl acetate layer of methanol extract of Aquilaria hulls for killing cancer cells and treating/preventing cancers and its uses. In particular, the extract is from Aquilaria agallocha Roxb. and has significant amount of cucurbitacins.
BACKGROUND OF
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to uses of an extract of dehulled adlay seeds; more particularly, to the treatment of breast cancer.
2. Description of the Related Art
Adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) is a grass crop and mainly planted in
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to uses of an extract of dehulled adlay seeds; more particularly, to the treatment of gastric ulcer and/or stomach cancer.
2. Description of the Related Art
Gastric hyperacidity and gastroduodenal ulcers are a very common
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a novel anti-cancer compound identified in mycelium of Antrodia camphorata, the methods of cultivation, and applications of the said compound. To be more specific, the extracted compound is a bioactive anti-cancer
BACKGROUND OF THE INVENTION
Black cohosh, Actaea racemosa L. (Cimicifuga racemosa), a perennial in the buttercup family (Ranunculaceae), is frequently used to treat gynecological and other conditions. In particular, the roots and rhizomes of black cohosh have been used to treat a variety of
BACKGROUND OF THE INVENTION
Black cohosh, Actaea racemosa L. (Cimicifuga racemosa), a perennial in the buttercup family (Ranunculaceae), is frequently used to treat gynecological and other conditions. In particular, the roots and rhizomes of black cohosh have been used to treat a variety of
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Stage Application of International Application No. PCT/CN2013/075235 filed on May 7, 2013, and published in Chinese as WO 2013/174207 A1 on Nov. 28, 2013. This application claims priority to Chinese Application No.
FIELD OF THE INVENTION
The present invention relates to a protein tyrosine phosphatase inhibitor, to method for preparing the same, and to use thereof in the manufacture of a pharmaceutical composition for the treatment and prevention of diabetes, obesity and cancers.
BACKGROUND OF THE
The present invention relates to a novel process for the preparation of Erlotinib of formula-(1) whose chemical name is N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, and its pharmaceutically acceptable salts thereof. Erlotinib is an inhibitor of the erbB family of oncogenic and
CROSS-REFERENCE TO RELATED APPLICATION
This U.S. application claims priority under 35 U.S.C. 371 to, and is a U.S. National Phase application of, the International Patent Application No. PCT/IN2015/000236, filed 10 Jun. 2015, which claims priority from Indian Patent Application No. 1614/DEL/2014
The following examples illustrate the present invention, but it is to be understood that they are given for the purpose of illustration and not limitation.
EXAMPLE 1
A medium (100 l) containing 6.0% soluble starch, 4.0% cotton seed meal, 0.2% (NH.sub.4).sub.2 SO.sub.4, 0.1% yeast extract, 0.2%
This invention relates to a process for the preparation of xanthophyll crystals. This invention particularly relates to a process for the preparation of xanthophyll crystals containing high content of trans-lutein and/or zeaxanthin. This invention more particularly relates to a process for the